|Articles|April 2, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-04-02-2018
  • Volume 42
  • Issue 4

Additional Certifications for Touchscreen Panels

Ross Systems and Controls (SysCon) touchscreen purged panels have been certified under the standards of Underwriters Laboratories’ (UL)-698A Code and the National Fire Protection Association’s (NFPA)-496 Code.

Ross Systems and Controls (SysCon) touchscreen purged panels for Ross, Charles & Son’s mixers, blenders, and other types of equipment and processes have been certified under the standards of Underwriters Laboratories’ (UL)-698A Code and the National Fire Protection Association’s (NFPA)-496 Code. The new certifications are in addition to UL-508A (non-hazardous control panels).

The UL-698A certification involves industrial control panels designed for hazardous locations, including the use of safe barriers. NFPA-496 standards relate to purged and pressurized enclosures.

According to the company, purge systems, which are an alternative to traditional National Electrical Manufacturers Association (NEMA) standards 7 and 9 explosion proof enclosures, are suited for most hazardous locations, including class I, division I and II for gas and vapor environments as well as class II, division I and II for dust environments. Purge panel enclosures can be NEMA 4 carbon steel or NEMA 4x stainless steel depending upon regulatory or aesthetic requirements, the company reports.

Ross, Charles & Son

Articles in this issue


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.